These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16436718)

  • 1. CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.
    D'Andrea MM; Nucleo E; Luzzaro F; Giani T; Migliavacca R; Vailati F; Kroumova V; Pagani L; Rossolini GM
    Antimicrob Agents Chemother; 2006 Feb; 50(2):618-24. PubMed ID: 16436718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities.
    Migliavacca R; Nucleo E; D'Andrea MM; Spalla M; Giani T; Pagani L
    New Microbiol; 2007 Jul; 30(3):295-8. PubMed ID: 17802913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis.
    Mata C; Navarro F; Miró E; Walsh TR; Mirelis B; Toleman M
    J Antimicrob Chemother; 2011 Oct; 66(10):2266-70. PubMed ID: 21752830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.
    Literacka E; Empel J; Baraniak A; Sadowy E; Hryniewicz W; Gniadkowski M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4136-43. PubMed ID: 15504832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY; Ng SY; Teo L; Koh Y; Teok CH
    J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07.
    Rodríguez I; Barownick W; Helmuth R; Mendoza MC; Rodicio MR; Schroeter A; Guerra B
    J Antimicrob Chemother; 2009 Aug; 64(2):301-9. PubMed ID: 19474065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel.
    Navon-Venezia S; Chmelnitsky I; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2008 Aug; 62(2):289-95. PubMed ID: 18487232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF].
    Treviño M; Navarro D; Barbeito G; Areses P; García-Riestra C; Regueiro BJ
    Rev Esp Quimioter; 2012 Jun; 25(2):122-8. PubMed ID: 22707100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales.
    Hopkins KL; Batchelor MJ; Liebana E; Deheer-Graham AP; Threlfall EJ
    Int J Antimicrob Agents; 2006 Sep; 28(3):180-92. PubMed ID: 16879949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of AmpC-mediated resistance in clinical Salmonella isolates recovered from humans during the period 1992 to 2003 in England and Wales.
    Batchelor M; Hopkins KL; Threlfall EJ; Clifton-Hadley FA; Stallwood AD; Davies RH; Liebana E
    J Clin Microbiol; 2005 May; 43(5):2261-5. PubMed ID: 15872253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
    Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
    Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and phenotypic characterization of the bla(CMY) gene from Escherichia coli and Salmonella enterica isolated from food-producing animals, humans, the environment, and retail meat.
    Heider LC; Hoet AE; Wittum TE; Khaitsa ML; Love BC; Huston CL; Morley PS; Funk JA; Gebreyes WA
    Foodborne Pathog Dis; 2009 Dec; 6(10):1235-40. PubMed ID: 19743925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMY-2 beta-lactamase-carrying community-acquired urinary tract Escherichia coli: genetic correlation with Salmonella enterica serotypes Choleraesuis and Typhimurium.
    Wu TL; Chia JH; Su LH; Chiu CH; Kuo AJ; Ma L; Siu LK
    Int J Antimicrob Agents; 2007 Apr; 29(4):410-6. PubMed ID: 17300921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid typing and genetic context of AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007.
    Mata C; Miró E; Alvarado A; Garcillán-Barcia MP; Toleman M; Walsh TR; de la Cruz F; Navarro F
    J Antimicrob Chemother; 2012 Jan; 67(1):115-22. PubMed ID: 21980067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe.
    D'Andrea MM; Literacka E; Zioga A; Giani T; Baraniak A; Fiett J; Sadowy E; Tassios PT; Rossolini GM; Gniadkowski M; Miriagou V
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2735-42. PubMed ID: 21402851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CMY-2-type plasmid-mediated AmpC ß-lactamases emerging in Tucumán, Argentina].
    Jure MA; Presti C; Cudmani NM; Grellet LM; López C; Musa EH; Aulet OC; Nieto C; Saavedra L; de Castillo MC
    Rev Argent Microbiol; 2011; 43(1):24-7. PubMed ID: 21491062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of ESbetaL producing P. mirabilis strains from a long-term care and rehabilitation facility in Italy.
    Migliavacca R; Migliavacca A; Nucleo E; Ciaponi A; Spalla M; De Luca C; Pagani L
    New Microbiol; 2007 Jul; 30(3):362-6. PubMed ID: 17802927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19.
    Wachino J; Kurokawa H; Suzuki S; Yamane K; Shibata N; Kimura K; Ike Y; Arakawa Y
    Antimicrob Agents Chemother; 2006 Feb; 50(2):534-41. PubMed ID: 16436707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.